Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Spanish eTIPS for Early Therapy in Perinatal Stroke (eTIPS-ES)

18 maggio 2026 aggiornato da: University of Castilla-La Mancha

Spanish eTIPS: Translation, Cross-Cultural Adaptation, and Pilot Randomized Feasibility Study of Early Therapy in Perinatal Stroke for Spanish-Speaking Families

This study adapts and evaluates the Spanish version of eTIPS, an early home-based therapy program for infants at risk of unilateral cerebral palsy after perinatal stroke. The project has three parts: translation and cultural adaptation of the original materials, a pilot randomized feasibility study comparing eTIPS with usual care, and a qualitative study exploring family experiences, barriers, and facilitators to using the program at home.

In the first part, the study team will translate and culturally adapt the eTIPS materials for Spanish-speaking families, review them with experts, and test whether the content is clear, relevant, and usable. In the second part, families with infants diagnosed with perinatal stroke or at high risk of unilateral cerebral palsy will be assigned to either the eTIPS program or usual clinical care to assess recruitment, retention, adherence, safety, acceptability, and preliminary effects on infant motor development and family outcomes. In the third part, caregivers in the intervention group will take part in interviews to better understand how the program fits into daily life and what could improve future implementation.

Panoramica dello studio

Descrizione dettagliata

This is a mixed-methods study designed to translate, culturally adapt, and evaluate the Spanish version of eTIPS, an early, parent-delivered therapy program originally developed for infants with perinatal stroke and risk of unilateral cerebral palsy. The project follows a staged approach with three linked phases: Phase I, translation and cross-cultural adaptation of the intervention materials; Phase II, a pilot randomized feasibility study; and Phase III, a qualitative study of family experiences and implementation.

Phase I will include forward translation, back-translation, expert review, and feedback from caregivers and professionals to ensure semantic, conceptual, and cultural equivalence of the Spanish materials. Phase II will randomize eligible infants to eTIPS or usual care, with the intervention delivered by caregivers in the home environment and supported by the research team. Outcomes in this phase will focus on feasibility and process measures such as eligibility, recruitment, consent, retention, adherence, usability, safety, and fidelity, as well as exploratory infant and caregiver outcomes.

The infant assessments may include measures of hand function, motor development, neurological status, and stroke-related outcomes, while caregiver outcomes may include well-being, stress, competence, and bonding. Phase III will use semi-structured interviews and thematic analysis to explore how caregivers experience the intervention in everyday routines, including perceived benefits, barriers, facilitators, and suggestions for improvement. The results will be used to refine the Spanish eTIPS program and inform the design of a future definitive multicenter trial.

Tipo di studio

Interventistico

Iscrizione (Stimato)

20

Fase

  • Non applicabile

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Infants with confirmed unilateral perinatal stroke diagnosis by neuroimaging, identified within first 3 months of life
  • Age at recruitment ≤3 months postnatal (intervention starts when clinically stable, maximum term-equivalent age)
  • Written informed consent from parents/legal guardians

Exclusion Criteria:

  • Known progressive neurodegenerative disorder or severe medical comorbidity preventing participation (e.g., ventilation-dependent respiratory failure)
  • Extensive bilateral intracerebral lesion making lateralized intervention irrelevant
  • Concurrent participation in another clinical trial with interfering treatment

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: eTIPS Intervention
Participants assigned to this arm will receive the Spanish-adapted eTIPS program, a parent-delivered, home-based early intervention for infants with perinatal stroke or risk of unilateral cerebral palsy. Families will receive training, adapted materials, and ongoing support to integrate lateralized therapeutic activities into daily routines from enrollment until corrected age 6 months.
Parent-delivered, home-based early therapy for infants with perinatal stroke or risk of unilateral cerebral palsy. Families receive the Spanish-adapted eTIPS materials, training, and ongoing support to integrate lateralized therapeutic activities into daily routines from enrollment until corrected age 6 months. The intervention is delivered alongside usual clinical care
Comparatore attivo: Usual Care
Participants assigned to this arm will receive usual clinical care according to local practice, including standard neonatal, neurological, and rehabilitation follow-up. This arm serves as the comparator for feasibility, acceptability, and exploratory outcome assessment
Standard neonatal, neurological, and rehabilitation follow-up according to local clinical practice. Includes routine pediatric neurology monitoring, periodic neurological evaluations to track motor development and detect early signs of unilateral cerebral palsy, and referral to pediatric rehabilitation with physiotherapy sessions (1 session/week or biweekly, 30-45 minutes) focused on mobilizations, muscle tone control, joint range maintenance, general sensory stimulation, and basic postural guidelines.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Recruitment Rate
Lasso di tempo: From identification to enrollment (baseline)
Proportion of eligible infants identified in neonatology/pediatric neurology who accept participation. Success criterion: ≥70% acceptance rate
From identification to enrollment (baseline)
Retention Rate
Lasso di tempo: 6 months (end of intervention)
Percentage of families completing the 6-month follow-up. Success criterion: ≥80% retention
6 months (end of intervention)
Adherence Rate
Lasso di tempo: Daily/weekly during 6 months
Days per week and minutes per week of practice recorded in digital diary/app. Success criterion: ≥70% practice days
Daily/weekly during 6 months

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Usability (SUS Score)
Lasso di tempo: Post-intervention (6 months)
System Usability Scale (SUS) score for materials and platform. Target: ≥70 points
Post-intervention (6 months)
Safety
Lasso di tempo: Throughout 6 months
Adverse events or incidents related to intervention (excessive fatigue, persistent rejection, feeding worsening)
Throughout 6 months
Parental Satisfaction
Lasso di tempo: Post-Intervention (6 months)
Likert-scale questionnaire on experience, confidence gained, and recommendation of program
Post-Intervention (6 months)
Fidelity
Lasso di tempo: Monthly during 6 months
Professional observation of correct eTIPS technique application during scheduled visits
Monthly during 6 months

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Hand Assessment for Infants (HAI)
Lasso di tempo: Baseline, 3 months, 6 months, 12 months
Video-based observational assessment of unimanual and bimanual hand function
Baseline, 3 months, 6 months, 12 months
Infant Motor Profile (IMP)
Lasso di tempo: Baseline, 3 months, 6 months
Structured observation of fine and gross motor patterns
Baseline, 3 months, 6 months
Paediatric Stroke Outcome Measure (PSOM)
Lasso di tempo: Baseline, 3 months, 6 months
Neurological and functional sequelae monitoring post-stroke
Baseline, 3 months, 6 months
Bayley Scales of Infant Development (BSID-IV)
Lasso di tempo: Baseline, 3 months, 6 months, 12 months
Standardized assessment of cognitive, motor and socio-emotional development in children from 1 to 42 months.
Baseline, 3 months, 6 months, 12 months
Hammersmith Infant Neurological Examination (HINE)
Lasso di tempo: Baseline, 3 months, 6 months
Standardized neurological assessment for infants 2-24 months evaluating motor and neurological development
Baseline, 3 months, 6 months
Parenting Sense of Competence (PSOC)
Lasso di tempo: Baseline, 3 months, 6 months
Questionnaire measuring parental perception of competence in child care and education
Baseline, 3 months, 6 months
Warwick-Edinburgh Mental Well-Being Scale (WEMWBS)
Lasso di tempo: Baseline, 3 months, 6 months
Brief scale measuring psychological and emotional well-being in primary caregivers
Baseline, 3 months, 6 months
Family Empowerment Scale
Lasso di tempo: Baseline, 6 months
Measures family perception of empowerment in caring for and supporting child with special needs
Baseline, 6 months
Edinburgh Postnatal Depression Scale (EPDS)
Lasso di tempo: Baseline, 3 months, 6 months
10-item self-report screening for postpartum depressive symptoms (cut-off ≥10/12). Spanish validated
Baseline, 3 months, 6 months
Parenting Stress Index - Short Form (PSI-SF)
Lasso di tempo: Baseline, 3 months, 6 months
36-item measure of parental stress across 3 subscales: Parental Distress, Parent-Child Dysfunctional Interaction, Difficult Child
Baseline, 3 months, 6 months
Postpartum Bonding Questionnaire (PBQ)
Lasso di tempo: Baseline, 3 months, 6 months
25-item questionnaire assessing mother-infant bonding quality. Detects rejection, anger, infantification (cut-off ≥12 factor 1)
Baseline, 3 months, 6 months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 settembre 2026

Completamento primario (Stimato)

31 luglio 2028

Completamento dello studio (Stimato)

31 dicembre 2028

Date di iscrizione allo studio

Primo inviato

18 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

18 maggio 2026

Primo Inserito (Effettivo)

26 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

26 maggio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

18 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • Spanish eTIPS

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

No plan to share individual participant data (IPD). Data will be stored securely at Universidad de Castilla-La Mancha following Spanish and EU data protection regulations (RGPD/LOPDGDD). Aggregate results will be published in peer-reviewed journals.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi